Preventing Adverse Drug Events With PatientSite

Clinical trial NCT00140504 · COMPLETED

Trial details

NCT number: NCT00140504
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Adverse Drug Event

Start date: 2003-04-01
Primary completion: 2004-12-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.